TriSalus Life Sciences (TLSIW) Non-Current Assets (2020 - 2026)

TriSalus Life Sciences (TLSIW) has 7 years of Non-Current Assets data on file, last reported at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 19.5% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $12.3 million (down 17.97% YoY), and the FY2025 full-year result was $3.1 million, down 6.51% from the prior year.
• Non-Current Assets for Q1 2026 stood at $2.8 million, down from $3.1 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $251.0 million in Q3 2022 and bottomed at $2.8 million in Q1 2026.
• The 5-year median for Non-Current Assets is $4.5 million (2024), against an average of $48.7 million.
• The widest annual swing landed in 2022, when Non-Current Assets grew 0.38%; it then slumped 98.2% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $4.8 million in 2022, then retreated by 21.86% to $3.7 million in 2023, then slipped by 11.62% to $3.3 million in 2024, then retreated by 6.51% to $3.1 million in 2025, then decreased by 7.97% to $2.8 million in 2026.
• The last three Non-Current Assets figures came in at $2.8 million (Q1 2026), $3.1 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.

Peer Comparison